ARTICLE
11 April 2016

It Was Only A Matter Of Time – DEA Revisiting Federal Status Of Marijuana

23 states, plus the District of Columbia and Guam permit some form of medical marijuana use.
United States Food, Drugs, Healthcare, Life Sciences
To print this article, all you need is to be registered or login on Mondaq.com.

23 states, plus the District of Columbia and Guam permit some form of medical marijuana use. And, there are various medical marijuana ballot provisions, including currently in Florida, which likely will lead to more states permitting medical marijuana after this November's election.

Despite the overwhelming change of law at the state level, federal law still classifies marijuana as a Schedule I drug. Schedule I drugs are defined as having "no currently accepted medical use and a high potential for abuse." So, its no surprise that with almost half the states approving medical use of marijuana there would come a time in which the Drug Enforcement Administration ("DEA") would have to revisit marijuana's classification. That time is now, with the DEA indicating it will issue new guidance on marijuana during the first half of 2016

Descheduling, or the more likely rescheduling, could, over time, have a big impact on employers seeking to enforce a "drug free workplace." Employers do not violate the Americans with Disability Act ("ADA") when they test for illegal drugs, but if marijuana becomes a descheduled or rescheduled drug, the gray area as to the legal treatment of marijuana grows grayer.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See More Popular Content From

Mondaq uses cookies on this website. By using our website you agree to our use of cookies as set out in our Privacy Policy.

Learn More